Literature DB >> 5296381

The diet, physical activity and accommodation of patients with quiescent pulmonary tuberculosis in a poor South Indian community. A four-year follow-up study.

C V Ramakrishnan, K Rajendran, K Mohan, W Fox, S Radhakrishna.   

Abstract

A previous report from the Tuberculosis Chemotherapy Centre, Madras, has shown that, if standard chemotherapy is given for one year, the response of patients treated at home in very poor environmental circumstances is nearly as good as that of those treated in sanatorium under much more favourable conditions. This paper reports on a four-year follow-up of all the patients whose disease was bacteriologically quiescent at the end of the year's treatment. During this period, all the patients were managed on a domiciliary basis; about a quarter of them received chemotherapy with isoniazid alone for two years, another quarter received the drug for one year and the rest received no specific chemotherapy. Despite adverse environmental factors (poor diet; long hours of work often involving strenuous physical activity; overcrowded living conditions; and, for the sanatorium patients, the stresses of returning suddenly to the unfavourable home environment), the great majority of patients in both series maintained quiescent disease throughout the follow-up period. Furthermore, the few patients whose disease relapsed bacteriologically were at no special dietary disadvantage in comparison with those who maintained quiescent disease throughout, nor did they show any appreciable differences in occupation, physical activity or living accommodation. These findings, together with the earlier ones, indicate that, despite adverse environmental circumstances, standard chemotherapy for an adequate period of time is sufficient in the great majority of patients for the attainment of bacteriological quiescence and its maintenance thereafter.

Entities:  

Mesh:

Year:  1966        PMID: 5296381      PMCID: PMC2475997     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Authors:  S VELU; R H ANDREWS; S DEVADATTA; W FOX; S RADHAKRISHNA; C V RAMAKRISHNAN; J B SELKON; P R SOMASUNDARAM; T V SUBBAIAH
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

2.  An assessment of reliability of the oral questionnaire method of diet survey as applied to Indian communities.

Authors:  S PASRICHA
Journal:  Indian J Med Res       Date:  1959-03       Impact factor: 2.375

3.  The initiation of chemotherapy in pulmonary tuberculosis in West Africans. Hospital and ambulant treatment compared using streptomycyclidine-isonicotinic acid hydrazide.

Authors:  W J BELL
Journal:  Br J Dis Chest       Date:  1960-07

4.  A survey of dietary intake in a group of poor, pregnant and lactating women.

Authors:  S PASRICHA
Journal:  Indian J Med Res       Date:  1958-07       Impact factor: 2.375

5.  The role of diet in the treatment of pulmonary tuberculosis. An evaluation in a controlled chemotherapy study in home and sanatorium patients in South India.

Authors:  C V RAMAKRISHNAN; K RAJENDRAN; P G JACOB; W FOX; S RADHAKRISHNA
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

6.  Progress in the second and third years of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate.

Authors:  S DEVADATTA; R H ANDREWS; J H ANGEL; A L BHATIA; W FOX; B JANARDHANAM; S RADHAKRISHNA; C V RAMAKRISHNAN; T V SUBBAIAH; S VELU
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  6 in total
  8 in total

Review 1.  Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis.

Authors:  W Fox
Journal:  Proc R Soc Med       Date:  1977-01

2.  Effect of pyridoxine on vitamin B6 concentrations and glutamic-oxaloacetic transaminase activity in whole blood of tuberculous patients receiving high-dosage isoniazid.

Authors:  D V Krishnamurthy; J B Selkon; K Ramachandran; S Devadatta; D A Mitchison; S Radhakrishna; H Stott
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

3.  [West German Public Health Service and the fight against tuberculosis].

Authors:  G Neumann
Journal:  Pneumonologie       Date:  1971

4.  Two controlled studies of the efficacy of isoniazid alone in preventing relapse in patients with bacteriologically quiescent pulmonary tuberculosis at the end of one year of chemotherapy.

Authors:  O Nazareth; S Devadatta; W Fox; N K Menon; S Radhakrishna; D Rajappa; C V Ramakrishnan; P R Somasundaram; H Stott; S Subbammal; S Velu
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

5.  Attack rate of tuberculosis in a 5-year period among close family contacts of tuberculous patients under domiciliary treatment with isoniazid plus PAS or isoniazid alone.

Authors:  S Devadatta; J J Dawson; W Fox; B Janardhanam; S Radhakrishna; C V Ramakrishnan; S Velu
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

6.  A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.

Authors:  J J Dawson; S Devadatta; W Fox; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S P Tripathy; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

7.  A controlled study of the influence of segregation of tuberculous patients for one year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India.

Authors:  S R Kamat; J J Dawson; S Devadatta; W Fox; B Janardhanam; S Radhakrishna; C V Ramakrishnan; P R Somasundaram; H Stott; S Velu
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

8.  A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.

Authors:  C Evans; S Devadatta; W Fox; P R Gangadharam; N K Menon; C V Ramakrishnan; S Sivasubramanian; P R Somasundaram; H Stott; S Velu
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.